Research Shows Montagu Helps Diabetes
A study conducted by Eli Lilly revealed that the use of the drug "Mounjaro" (Tirzepatide) enhances the control of type 2 diabetes in patients, especially in cases that did not respond to traditional treatments. The results showed that patients who received weekly injections experienced improvements in blood sugar levels and weight after two years, with approximately 60% achieving normal blood sugar levels compared to 24% in the other group. The study suggests that early initiation of "Mounjaro" treatment could offer greater benefits for more sustainable disease management.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)